Pulkkinen J - Search Results

1

Oropharyngeal carcinoma and its treatment in Finland between 1995-1999: a nationwide study.

Mäkitie AA, Pukkila M, Laranne J, Pulkkinen J, Vuola J, Bäck L, Koivunen P, Grénman R. Mäkitie AA, et al. Among authors: pulkkinen j. Eur Arch Otorhinolaryngol. 2006 Feb;263(2):139-43. doi: 10.1007/s00405-005-0975-5. Epub 2005 Jul 8. Eur Arch Otorhinolaryngol. 2006. PMID: 16003551

2

Paclitaxel-induced apoptotic changes followed by time-lapse video microscopy in cell lines established from head and neck cancer.

Pulkkinen JO, Elomaa L, Joensuu H, Martikainen P, Servomaa K, Grenman R. Pulkkinen JO, et al. J Cancer Res Clin Oncol. 1996;122(4):214-8. doi: 10.1007/BF01209648. J Cancer Res Clin Oncol. 1996. PMID: 8601573

3

p53 mutations associated with increased sensitivity to ionizing radiation in human head and neck cancer cell lines.

Servomaa K, Kiuru A, Grénman R, Pekkola-Heino K, Pulkkinen JO, Rytömaa T. Servomaa K, et al. Among authors: pulkkinen jo. Cell Prolif. 1996 May;29(5):219-30. doi: 10.1046/j.1365-2184.1996.01009.x. Cell Prolif. 1996. PMID: 8782485

4

Paclitaxel and irradiation induce apoptosis in squamous cell carcinoma cell lines in an additive way.

Pulkkinen JO, Pekkola-Heino K, Grénman R. Pulkkinen JO, et al. Anticancer Res. 1996 Sep-Oct;16(5A):2923-9. Anticancer Res. 1996. PMID: 8917408

5

Syndecan-1: a new prognostic marker in laryngeal cancer.

Pulkkinen JO, Penttinen M, Jalkanen M, Klemi P, Grénman R. Pulkkinen JO, et al. Acta Otolaryngol. 1997 Mar;117(2):312-5. doi: 10.3109/00016489709117794. Acta Otolaryngol. 1997. PMID: 9105473

6

The bcl-2 gene status of human head and neck cancer cell lines.

Salo A, Servomaa K, Kiuru A, Pulkkinen J, Grénman R, Pekkola-Heino K, Rytömaa T. Salo A, et al. Among authors: pulkkinen j. Acta Otolaryngol Suppl. 1997;529:233-6. Acta Otolaryngol Suppl. 1997. PMID: 9288319

7

p53 mutations in human head and neck cancer cell lines.

Kiuru A, Servomaa K, Grénman R, Pulkkinen J, Rytömaa T. Kiuru A, et al. Among authors: pulkkinen j. Acta Otolaryngol Suppl. 1997;529:237-40. doi: 10.3109/00016489709124132. Acta Otolaryngol Suppl. 1997. PMID: 9288320

8

Apoptosis in situ, p53, bcl-2 and AgNOR counts as prognostic factors in laryngeal carcinoma.

Pulkkinen JO, Klemi P, Martikainen P, Grénman R. Pulkkinen JO, et al. Anticancer Res. 1999 Jan-Feb;19(1B):703-7. Anticancer Res. 1999. PMID: 10216480

9

Effects of paclitaxel with or without cremophor EL on cellular clonogenic survival and apoptosis.

Engblom P, Pulkkinen JO, Rantanen V, Hirvonen H, Kulmala J, Grènman R, Grènman S. Engblom P, et al. Among authors: pulkkinen jo. Eur J Cancer. 1999 Feb;35(2):284-8. doi: 10.1016/s0959-8049(98)00298-6. Eur J Cancer. 1999. PMID: 10448272

10

The effect of irradiation on mitotic and apoptotic frequency in head and neck cancer cell lines, the correlation to p53 mutations and clonogenic survival.

Pulkkinen JO, Servomaa K, Pekkola K, Kulmala J, Grenman R. Pulkkinen JO, et al. Anticancer Res. 2000 May-Jun;20(3A):1503-11. Anticancer Res. 2000. PMID: 10928063

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

109 results

Search Page

Filters